Genomic imbalance in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine

被引:0
|
作者
Yu, MS [1 ]
Ryu, DY [1 ]
Snyderwine, EG [1 ]
机构
[1] NCI, Chem Carcinogenesis Sect, Expt Carcinogenesis Lab, Bethesda, MD 20892 USA
关键词
PhIP; mammary gland; rat;
D O I
10.1002/(SICI)1098-2744(200002)27:2<76::AID-MC3>3.0.CO;2-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine (PhlP), a compound found in cooked meat, is a mammary gland carcinogen in female Sprague-Dawley rats. PhlP-induced rat mammary gland carcinomas were examined for mutations in several genes (exons) known to regulate cell growth and apoptosis, including p53 (4-8), p21(Waf1) (coding region), Apc(14, 15), B-catenin (3), E-cadherin (9,13,15), Bcl-x(coding region), Bar (3), IGFIIR (28), and TGFBIIR (3). DNA from 30 carcinomas was examined by single-strand conformation polymorphism analysis, but no mutations were detected in these genes or gene regions. DNA from carcinomas and matching normal tissue were further screened for allelic imbalance by using a polymerase chain reaction-based approach with primers to known microsatellite regions located throughout the rat genome. Of 53 markers examined, 12 revealed allelic imbalance. Microsatellite instability (MSI) was detected at two markers, one an chromosome 4 and one on chromosome 6. Sixty-five percent and 96% of all carcinomas examined (N=23) showed MSI at these loci on chromosomes 4 and 6, respectively, supporting the notion that MSI plays a role in PhlP-induced mammary carcinogenesis. Loss of heterozygosity (LOH), an indication of a possible tumor suppressor gene, was observed at 10 markers distributed on chromosomes 3, 10, 11, 14, and X. The frequency of LOH at these markers was 75-94%, supporting that the regions of allelic imbalance were largely similar for the PhlP-induced carcinomas examined in this study. When PhlP-induced carcinomas from rats placed on high-fat and low-fat diet were compared, no unique regions of allelic imbalance or statistical differences in the frequency of allelic imbalance were observed. Therefore, the high-fat diet, known to be a promoter of PhlP-induced rat mammary carcinogenesis, did not appear to influence allelic imbalance in the carcinomas. Interestingly, 7,12-dimethylbenz[a]anthracene-induced mammary carcinomas did not show allelic imbalance at 11 of the 12 loci that showed allelic imbalance in PhlP-induced carcinomas. These findings suggest that distinct chemical carcinogens induce different patterns of allelic imbalance during rat mammary carcinogenesis. Since several of the known genes involved in carcinogenesis did not harbor mutations in PhlP-induced carcinomas, further studies are needed to clarify the critical genes involved in PhlP-induced mammary carcinogenesis and to determine whether regions of LOH harbor potentially novel tumor suppressor genes involved in this disease. (C) 2000 Wiley-Liss, Inc.
引用
收藏
页码:76 / 83
页数:8
相关论文
共 50 条
  • [1] Steroid hormone receptor expression and proliferation in rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
    Qiu, CP
    Shan, L
    Yu, MS
    Snyderwine, EG
    CARCINOGENESIS, 2005, 26 (04) : 763 - 769
  • [2] mRNA differential display of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary gland tumors
    Sarah J. Roberts-Thomson
    Elizabeth G. Snyderwine
    Breast Cancer Research and Treatment, 1998, 51 : 99 - 107
  • [3] Mammary gland carcinogenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats:: possible mechanisms
    Snyderwine, EG
    CANCER LETTERS, 1999, 143 (02) : 211 - 215
  • [4] Carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat
    Ito, N
    Hasegawa, R
    Imaida, K
    Tamano, S
    Hagiwara, A
    Hirose, M
    Shirai, T
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1997, 376 (1-2) : 107 - 114
  • [5] Reduced Brca1 protein expression in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary carcinomas
    Okochi, E
    Miyamoto, K
    Wakazono, K
    Shima, H
    Sugimura, T
    Ushijima, T
    MOLECULAR CARCINOGENESIS, 2002, 34 (04) : 211 - 218
  • [6] Possible role of elevated phosphoSTAT5a in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary gland carcinomas.
    Papaconstantinou, Andriana D.
    Snyderwine, Elizabeth G.
    CANCER RESEARCH, 2006, 66 (08)
  • [7] cDNA microarray profiling of rat mammary gland carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 7,12-dimethylbenz[a]anthracene
    Shan, L
    He, M
    Yu, MS
    Qiu, CP
    Lee, NH
    Liu, ET
    Snyderwine, EG
    CARCINOGENESIS, 2002, 23 (10) : 1561 - 1568
  • [8] Chemoprevention of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine-induced mammary carcinogenesis in rats
    Mori, H
    Sugie, S
    Rahman, W
    Suzui, N
    CANCER LETTERS, 1999, 143 (02) : 195 - 198
  • [9] Frequent c-Ha-ras gene mutations in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine
    Hokaiwado, N
    Asamoto, M
    Cho, YM
    Imaida, K
    Shirai, T
    CANCER LETTERS, 2001, 163 (02) : 187 - 190
  • [10] THE METABOLIC DISPOSITION OF 2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE IN THE INDUCED MOUSE
    TURTELTAUB, KW
    KNIZE, MG
    HEALY, SK
    TUCKER, JD
    FELTON, JS
    FOOD AND CHEMICAL TOXICOLOGY, 1989, 27 (10) : 667 - 673